Therefore , the need for a new antiplatelet agent with fast onset of action , less variability in response among individuals and improved safety profile is critical .
Still , the major concern with these methods above are increased risk of bleeding .
The need for a new antiplatelet agent with fast onset of action , less variability in response among individuals and improved safety profile is critical .
Still , the major concern with these methods above are increased risk of bleeding .